Ann: Research Cooperation Agreement with Largest , page-7

re: Ann: Research Cooperation Agreement with ... As mentioned previously, Biobot won't sell easily. When the company said in announcement they were improving the design and functionality of the robot to make it better I think they meant that their robots weren't ready for hospitals to buy it, as confirmed by some other speculative sources received ealier in the year. For those who read this week's Bloomberg news Regarding: Robot Surgery Damaging Patients Rises With Marketing , it may be fair to say that the revolution is yet too early, we may wait for ten years for market acceptance.

I owned the stock, for the potential some investments will pay off.